Emmaus Life Sciences Announces Submission of Marketing Authorization Application to the Saudi Food and Drug Authority Aug 18, 2020 8:00am EDT
Emmaus Life Sciences Reports Additional Positive Preliminary Results in Diverticulosis Pilot Trial Aug 05, 2020 8:00am EDT
Emmaus Life Sciences Receives Scientific Advice From the EMA Regarding Xyndari™ Jul 29, 2020 12:09pm EDT
Emmaus Life Sciences Accelerates Middle East and North Africa (MENA) Growth Strategy with Opening of its Dubai Office Jul 23, 2020 1:14pm EDT
Emmaus Life Sciences Announces Engagement of Partner International to Lead Out-Licensing of Endari® for Diverticulosis Jul 16, 2020 8:00am EDT
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Israeli Ministry of Health Jun 29, 2020 8:00am EDT
National Institutes of Health Announces Intention with Respect to Grant of Exclusive Patent License to Emmaus Life Sciences Jun 25, 2020 8:00am EDT
